Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
With an annual revenue of about $500 million, Spectrum will become part of the Industrial Solutions line of business within the Electronics & Industrial segment
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Subscribe To Our Newsletter & Stay Updated